Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 23, 2018Annals of the Rheumatic DiseasesOpen Access

Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial

View Full Paper
Ask AI
Bookmark
Share

Authors

JPJin Kyun ParkSeoul National UniversityYLYun Jong LeeSeoul National UniversityKSKichul ShinSeoul National University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Park et al. (2018) studied this question.

synapsesocial.com/papers/6a8375adc8eb9492e29ef086https://doi.org/10.1136/annrheumdis-2018-213222
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis1988 · 19,988 citations
  2. 2American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis2008 · 1,493 citations
  3. 3Effect of Methotrexate, Anti–Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis2013 · 305 citations
  4. 4The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis2015 · 197 citations